TEAM microscope breaks the angstrom barrier
A new TEM (transmission electron microscope) developed by the TEAM project has achieved 'the highest resolution images ever recorded' using the technique.
Archives for September 12, 2007
ZS Genetics puts DNA under the microscope
ZS Genetics has signed up outside academic assistance to speed up development of its 'revolutionary' microscopy-based genetic analysis technology platform.
bioMerieux buys standards innovator BTF
Industrial microbiology expert bioMerieux has acquired Australian firm BTF, strengthening its quality control (QC) and manufacturing quality assurance (QA) offerings to the pharmaceutical industry.
New funding drive for 'Eurostars'
The European Commission has named research-performing small and medium-sized enterprises (SMEs) as 'the entrepreneurial stars of Europe', and hopes to raise €800m of extra funds for them.
Celsis jumps on ADME-Tox services bandwagon
US-based pharma services firm Celsis International has announced the addition of ADME-Tox services to its portfolio thanks to a recent acquisition.
Genomic data could alleviate health impact of loneliness
Loneliness has been linked to serious diseases such as cancer, heart disease and infection but a new study could point to new ways of reducing its impact on health.
Wyeth backs Flamel drug delivery tech
Wyeth has signed a license agreement with French firm Flamel Technologies to apply the company's second innovative drug delivery technology to one of its protein therapeutics.
Aspartame safe, study says
A new report looking at the safety of aspartame has concluded there is "no credible evidence" the sweetener is unsafe.
Vivalis' EBx cell lines show more promise for MAbs
Vivalis is set to stamp out the Chinese Hamster Ovary (CHO) cell line competition as the French company announces initial results in a second study on monoclonal antibody production using its avian-derived cell line.
Novartis on NME trail
Novartis is aiming to hunt down its rivals through a pipeline of truly innovative drugs, measured by increasing numbers of New Molecular Entities (NMEs) in development.